3840EGP
- Active ingredient
- degarelix
- Strength
- 80mg
- Form
- vial
- Manufacturer
- ferring pharmaceuticals > multipharma
- Route
- injection
Uses
GnRH receptor antagonist used for the treatment of advanced prostate cancer.
Do not use if
History of severe hypersensitivity to degarelix or any component of the formulation.
Side effects
Common adverse effects include injection-site reactions, hot flashes, and elevated liver enzymes.
Warnings
Monitor for hypersensitivity reactions and QT interval prolongation.
How it works
Blocks pituitary GnRH receptors, reducing gonadotropin release and lowering testosterone levels.
Storage
Store at 20–25°C; excursions permitted between 15°C and 30°C.